Change of immunological parameters in the clinical course of a myasthenia gravis patient with chronic graft-versus-host disease

Pediatrics International

Volumn 38, Issue 2, 1996, Pages 151-155

  Hayashi, Masatoshi ^a   Matsuda, Osamu ^a   Ishida, Yasushi ^a   Kida, Kaichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti acetylcholine receptor antibody titer; GVHD; Lymphocyte subsets; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ANTIBODY TITER; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CELLULAR IMMUNITY; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTE SUBSETS; MALE; MYASTHENIA GRAVIS;

EID: 0029868031     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03459.x     Document Type: Article

References (24)

1. Drachman DB. Myasthenia gravis. N. Engl. J. Med. 1978; 298: 136–42.
2. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S., Duanne DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976; 26: 1054–9.
3. Hayashi M., Kida K., Yamada I. et al. Anti-acetylcholine receptor antibody in juvenile and adult myasthenia gravis. Acta Paediatr. Jpn. 1976; 28: 781–7.
4. Hayashi M., Kida K., Sonoda S., Inoue H., Matsuda H. Factors influencing the clinical type and course of myasthenia gravis. Brain Dev. 1992; 14: 88–93.
5. Kuroda Y., Oda K., Neshige R., Shibasaki H. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells. Ann. Neurol. 1984; 15: 400–2.
6. Sommer N., Harcourt GC, Willcox N., Beeson D., Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 1991; 41: 1270–6.
7. Shimizu H., Ichikawa Y., Yoshida M., Takahashi K., Arimori S. Lymphocyte subsets of the peripheral blood in myasthenia gravis determined by two-color flow cytometry. Autoimmunity 1990; 6: 173–82.
8. Gale RP. Graft-versus-host disease. Immunol. Rev. 1985; 88: 193–20.
9. Parkman R. Graft-versus-host disease: an alternative hypothesis. Immunol. Today 1989; 10: 362–3.
10. Smith CIE, Aarli JA, Biberfeld P. et al. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. N. Engl. J. Med. 1983; 309: 1565–8.
11. Bolger GB, Sullivan KM, Spence AM et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087–91.
12. Grau JM, Casademont J., Monforte R. et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant. 1990; 5: 435–7.
13. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol. Clin. 1988; 6: 389–403.
14. Lindstrom JM. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin. Immunol. Immunopathol. 1977; 7: 36–43.
15. Hayashi M., Takaoka T., Manabe K., Yoshinaga J., Kida K. Comparison of antibody titer to human and rat acetylcholine receptor in myasthenia gravis. Acta Paediatr. Jpn. 1995; 17: 38–41.
16. Fujii Y., Monden Y., Hashimoto J., Nakahara K., Kawashima Y. Acetylcholine receptor antibody production by bone marrow cells in a patient with myasthenia gravis. Neurology 1985; 35: 577–9.
17. Compston DAS, Vincent A., Newsom-Davis J., Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579–601.
18. Salvetti M., Jung S., Chang SF, Will H., Schalke BCG, Wekerle H. Acetylcholine receptor-specific T-lymphocyte clones in the normal human immune repertoire: target epitopes, HLA restriction, and membrane phenotypes. Ann. Neurol. 1991; 29: 508–16.
19. Hayashi M., Kida K., Yamada I. et al. Involvement of HLA in clinical courses of myasthenia gravis. J. Neuroimmunol. 1988; 18: 171–9.
20. Kida K., Hayashi M., Yamada I. et al. Heterogeneity in myasthenia gravis: HLA phenotypes and auto-antibody responses in ocular and generalized types. Ann. Neurol. 1987; 21: 274–8.
21. Lampert JA, Janossy G., Tidman N. et al. Immunological analysis of the skin in graft-versus-host disease. Clin. Exp. Immunol. 1982; 50: 123–31.
22. Wit DD, Mechelen MV, Zanin C. et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 1993; 150: 361–6.
23. Janeway CA. The co-receptor function of CD4. Semin. Immunol. 1991; 3: 153–60.
24. Lefvert AK. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis. Ann. Inst. Pasteur/Immunol. 1988; 139: 633–43.